/Companies

Aloetherapeutics

2 known investors

Find your way into Aloetherapeutics

Sign up to see every warm intro you have to Aloetherapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aloetherapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.

Investors · 2

Frequently asked questions

What does Aloetherapeutics do?
Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.
Who are Aloetherapeutics's investors?
Aloetherapeutics's investors include Maryland TEDCO, TEDCO.